Stocks to BUY: If you are thinking of investing in healthcare stocks, then brokerage firm Motilal Oswal has released a list of its 5 favorite stocks in this sector. According to the brokerage, investment in these shares can yield returns of up to 23.7 percent from the current level. This includes shares ranging from Apollo Hospitals to Sun Pharma and Piramal Pharma.
Apollo Hospitals
The brokerage firm has advised to buy this stock with a target price of Rs 5,700. One share of Apollo Hospitals is currently available on NSE at a price of Rs 5,081. In this way, the brokerage firm expects a further rise of about 12.18 percent in this stock.
Sun Pharmaceuticals
related news
The brokerage firm has advised to buy this share with a target price of Rs 1,310. One share of Sun Pharmaceuticals is currently available on NSE at a price of Rs 1,149.00. In this way, the brokerage firm expects a further rise of about 14.01 percent in this stock.
Solara Active Pharma Sciences
The brokerage firm has advised to buy this share with a target price of Rs 420. One share of Solara Active is currently available on NSE at a price of Rs 360.90. In this way, the brokerage firm expects a further rise of about 16.3 percent in this stock.
Also read- Nifty PSU Bank Index: Shares became rocket due to breakout after 13 years, now where is the earning opportunity next?
Granules India
The brokerage firm has advised to buy this share with a target price of Rs 370. One share of Granules India is currently available on NSE at a price of Rs 326.80. In this way, the brokerage firm expects a further rise of about 13.21 percent in this stock.
Piramal Pharma
The brokerage firm has advised to buy this share with a target price of Rs 125. One share of Piramal Pharma is currently available on NSE at a price of Rs 101.10. In this way, the brokerage firm expects a further rise of about 23.7 percent in this stock.
Disclaimer: The views and investment advice given by experts on Moneycontrol are their own and not those of the website and its management. Moneycontrol advises users to consult certified experts before taking any investment decision.
<
